AbstractGet full access to this articleView all access options for this article.Get accessReferences1. Yan H , Deng Q , Meng Y , et al. IL-21 and IL-33 May Be Effective Biomarkers to Predict the Efficacy of PD-1 Monoclonal Antibody for Advanced Cholangiocarcinoma. Cancer Biother Radiopharm, 2025; 40(1):78–88.
